Eales Disease is a rare eye disorder that primarily affects young adults, typically between the ages of 20 and 30. It is characterized by inflammation and progressive damage to the blood vessels in the retina, the light-sensitive tissue at the back of the eye. The exact cause of Eales Disease is unknown, but it is believed to be related to an abnormal immune response or a vascular disorder.
Symptoms: The most common symptom of Eales Disease is blurred vision, which may occur suddenly or gradually. Other symptoms include floaters (tiny specks or spots that appear in the field of vision), reduced peripheral vision, and in some cases, retinal hemorrhages.
Diagnosis: Diagnosis of Eales Disease involves a comprehensive eye examination, including visual acuity tests, dilated fundus examination, and imaging tests such as fluorescein angiography.
Treatment: There is no specific cure for Eales Disease, but treatment aims to manage the symptoms and prevent complications. This may involve the use of corticosteroids to reduce inflammation, laser photocoagulation to seal leaking blood vessels, or vitrectomy surgery in advanced cases.
Prognosis: The prognosis for individuals with Eales Disease varies depending on the severity of the condition and the promptness of treatment. With appropriate management, many people can maintain functional vision, although some may experience permanent vision loss.